Sunshine Biopharma (SBFMW) Cash & Equivalents Growth (3y) (2015 - 2026)
Sunshine Biopharma (SBFMW) Cash & Equivalents Growth (3y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.97 Bn | 36.23 Bn | 1.97 Bn | 20.41% |
| 2 | Zoetis | 33.59 Bn | 31.65 Bn | 1.62 Bn | -2.73% |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 3.22% |
| 4 | Neurocrine Biosciences | 16.10 Bn | 14.78 Bn | 800.70 Mn | 36.93% |
| 5 | Aurora Cannabis | 15.56 Bn | 15.47 Bn | 21.72 Mn | -37.05% |
| 6 | Elanco Animal Health | 12.04 Bn | 11.61 Bn | 785.00 Mn | 10.41% |
| 7 | Alkermes | 7.36 Bn | 6.84 Bn | -116.06 Mn | 3.03% |
| 8 | Lantheus Holdings | 6.74 Bn | 6.24 Bn | 230.92 Mn | 1.92% |
| 9 | Liquidia | 6.27 Bn | 6.04 Bn | 121.79 Mn | 33.13% |
| 10 | Sunshine Biopharma | - | - | 2.18 Mn | -28.97% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -28.97% |
| Dec 31, 2025 | -25.23% |
| Sep 30, 2025 | -38.78% |
| Jun 30, 2025 | -37.26% |
| Mar 31, 2025 | -14.89% |
| Dec 31, 2024 | 67.94% |
| Sep 30, 2024 | 72.29% |
| Jun 30, 2024 | 87.88% |
| Mar 31, 2024 | 113.30% |
| Dec 31, 2023 | 154.37% |
| Sep 30, 2023 | 237.85% |
| Jun 30, 2023 | 513.14% |
| Mar 31, 2023 | 1,113.09% |
| Dec 31, 2022 | 713.78% |
| Sep 30, 2022 | 690.91% |
| Jun 30, 2022 | 938.31% |
| Mar 31, 2022 | 417.42% |
| Dec 31, 2021 | 164.49% |
| Sep 30, 2021 | 271.82% |
| Jun 30, 2021 | 262.60% |